Exelixis
EXEL
#1590
Rank
$13.76 B
Marketcap
$54.77
Share price
2.89%
Change (1 day)
24.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company